Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 October 2024 | Story Precious Shamase | Photo Supplied
Sibahle Mabaso
Sibahle Mabaso during her BA (Hons) Drama and Theatre Arts (2022) graduation, which she passed cum laude.

Sibahle Mabaso, a talented and driven individual, has been making waves at the University of the Free State (UFS). As a runner-up in the prestigious Siyaphumelela ATD DREAM Scholar programme, Mabaso's dedication and achievements have not gone unnoticed.

A multi-faceted student, Mabaso excelled in both her academic pursuits and extracurricular activities. A graduate of the UFS Drama and Theatre Arts programme, Mabaso's academic pursuits have been as diverse as her interests. She has a BA in Drama and Theatre Arts (2019-2021), a BA Honours in Drama and Theatre Arts (2022), and she is currently pursuing a Master of Arts with specialisation in Gender Studies.  Her passion for the arts is evident in her work as a playwright, director, and educator. Mabaso is currently an Assistant Researcher in Transition, Development and Success within the Centre for Teaching and Learning.

Mabaso's journey to academic success has been marked by resilience and perseverance. Despite facing challenges, she has overcome obstacles through hard work, determination, and the support of mentors.

Beyond her academic achievements, Mabaso is committed to giving back to her community. She recently founded a creative enterprise called Wild Geese PTY LTD, which aims to provide opportunities for young creatives. Through her work, Mabaso hopes to inspire and mentor others, sharing her experiences and knowledge to help them reach their full potential.

As Mabaso continues her academic journey and pursues her career goals, her dedication and passion for both her studies and community engagement are sure to inspire others. Her achievements serve as a testament to the power of hard work, resilience, and a commitment to making a positive impact. Looking ahead, Mabaso hopes to continue her academic pursuits and pursue a career in higher education. She is also passionate about giving back to her community and mentoring young people. With her talent, dedication, and unwavering spirit, there is no doubt that Sibahle Mabaso will continue to achieve great things.

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept